Related Experiment Video
Updated: Apr 21, 2026

07:36
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
10.5K
Fighting for the next generation: US Prematurity in 2030
Edward R B McCabe1, Gerard E Carrino2, Rebecca B Russell2
1March of Dimes Foundation, White Plains, New York emccabe@marchofdimes.org.
Pediatrics
|November 5, 2014
Summary
Preterm birth (PTB) remains a significant concern in the US, affecting 1 in 9 newborns. Achieving an aspirational goal of 5.5% PTB by 2030 is possible and crucial for infant health.
Area of Science:
- Neonatal Health
- Public Health Initiatives
- Maternal-Fetal Medicine
Background:
- Preterm birth (PTB) affects over 450,000 US neonates annually, with rates peaking at 12.8% in 2006.
- Despite a decline to 11.4% by 2013, PTB remains a leading cause of neonatal mortality and lifelong disability.
- The societal cost of PTB is substantial, estimated at over $26.2 billion annually.
Purpose of the Study:
- To address the persistent challenge of preterm birth in the United States.
- To advocate for a reduction in the national preterm birth rate.
- To establish a benchmark for improved neonatal outcomes.
Main Methods:
- Analysis of national preterm birth rate trends since 1980.
- Benchmarking US PTB rates against Very High Human Development Index (VHHDI) countries.
- Review of successful PTB reduction strategies in comparable nations.
Main Results:
- The US experienced a significant rise in PTB from 1980 until 2006.
- The US PTB rate, though declining, remains high compared to other VHHDI countries.
- An aspirational goal of 5.5% PTB by 2030 is proposed, aligning with rates achieved in top-performing VHHDI nations.
Conclusions:
- The current US preterm birth rate is unacceptably high, leading to significant morbidity and mortality.
- Achieving a 5.5% preterm birth rate by 2030 is an attainable and critical goal for improving neonatal health.
- This ambitious target, achievable with optimal care, will enhance the start of life for future generations.
Related Concept Videos
Teratogenicity
4.1K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.1K
Development of the Oral Microbiota
58
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
58
Population Growth
22.4K
Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
22.4K
Prevalence and Incidence
2.3K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.3K
Mitral Valve Prolapse III: Nursing Management
568
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
568
Fetal Circulation
4.9K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
4.9K

